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Abstract: The complexes of Fe(II), Mn(II) and Ni(II) with a combination of a Schiff base, 
nitrogen-donor ligand or macrocyclic ligand and trithiocyanuric acid (ttcH3) were prepared 
and characterized by elemental analysis and spectroscopies. Crystal and molecular 
structures of the iron complex of composition [Fe(L1)](ttcH2)(ClO4)·EtOH·H2O (1), where 
L1 is Schiff base derived from tris(2-aminoethyl)amine and 2-pyridinecarboxaldehyde, 
were solved. It was found that the Schiff base is coordinated to the central iron atom by six 
nitrogens forming deformed octahedral arrangement, whereas trithiocyanurate(1-) anion, 
perchlorate and solvent molecules are not coordinated. The X-ray structure of the  
Schiff base sodium salt is also presented and compared with the iron complex. The 
anticholinesterase activity of the complexes was also studied. 
OPEN ACCESS
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1. Introduction 
The sodium salt of trithiocyanuric acid (ttcH3 = trithiocyanuric acid, also named as  
2,4,6-trimercapto-1,3,5-triazine (TMT)) readily forms precipitates with heavy metal ions and that is 
why it is used for removal of heavy metal ions from industrial wastewater. The effectiveness of heavy 
metal removal was widely studied by Atwood et al. [1–3] and other groups [4]. Removal of residual 
palladium and its compounds from reaction mixtures in preparation of drugs, in which palladium is 
used as a catalyst, is also very important [5,6]. 
Biological activity of trithiocyanuric compound was also evaluated as it can serve as a ligand of 
Toxoplasma gondii orotate phosphoribosyltransferase [7–9]. This enzyme is necessary for replication 
of the parasitic protozoan Toxoplasma gondii, which causes the disease toxoplasmosis. It was proved 
that trithiocyanuric acid is a better ligand for the enzyme than 5-fluorouracil and emimycin, which are 
used for clinical treatment of toxoplasmosis. Kar et al. prepared a series of trinuclear Ru(II) complexes 
of a composition [{Ru(L)2}3(ttc)](ClO4)3, where L = 2,2'-bipyridine, 1,10-phenanthroline and arylazo-
pyridine, which contain trithiocyanurate(3-) bridge bounding Ru(II) centers by chelating S,N donor sets 
of the anion [10,11]. In addition to the structural, electrochemical and spectral study, interaction of the 
complexes with the circular and linear forms of p-Bluescript DNA was reported. The Ru(II) complexes 
reduced the fluorescence intensity of both circular and linear DNA. Zn(II), Fe(II) and Mn(II) 
complexes with a combination of nitrogen-donor ligands and ttcH3 were prepared and their antitumor 
and antimicrobial activities were assayed [12]. The IC50 values of the Fe(II) and Mn(II) compounds 
turned out to be lower than those of cisplatin and oxaliplatin. 
Potentially six donor atoms can be used for coordination to metal centres. It is always difficult to 
avoid the formation of precipitates of unknown and probably polymeric structure with metal ions in the 
presence of deprotonated trithiocyanuric acid. Mostly blocking ligands on metal centres must be 
coordinated. Despite of that, bonding properties of trithiocyanuric acid complexes were proved by 
single crystal X-ray analysis. In some compounds, only deprotonated trithiocyanuric acid is present as 
anion not bonded to central atoms [13]. Mononuclear nickel and zinc complexes with nitrogen donor 
ligands and trithiocyanurate(2-) bonded by S and N have been structurally characterized [14–18]. 
Bridging, bischelating S,N mode was proved on cobalt complex [{Co(en)2}2(-ttc)](ClO4)3·2H2O  
(en = ethylenediamine) for the first time [19]. Metals preferring S donor atoms can form trinuclear 
species with coordination to S atoms only, for example in [{HgMe}3(-ttc)], [{SnMe3}3(-ttc)] and 
[{SnPh3}3(-ttc)] [20,21]. The hexanuclear [{AgPPh3}6(-ttc)2] complex with two parallel triazine 
rings held by six Cu-S bridges was characterized [22], as well as the Au(I) cluster [23] and Cu(I) 
polymer [24]. Trinuclear cyclopentadienyl complexes of rhodium and iridium were also  
reported [25,26]. Magnetic and structural studies on trinuclear copper complex with 1,3-bis(2-(4-
methylpyridyl)imino)isoindoline as blocking ligand and ttc were reported [27]. Pmdien (N,N,N',N'',N''-
pentamethyldiethylenetriamine) was proven to be a very good terdentate ligand for complexes with ttc. 
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Trinuclear complexes of compositions [M3(pmdien)3(-ttc)](ClO4)3, where M = Zn, Cu and Ni were 
prepared and structurally characterized [28–31]. 
The aim of this work was to prepare Fe(II), Mn(II) and Ni(II) complexes with nitrogen atom  
donors and trithiocyanurate anion. The complexes are of the following composition: 
[Fe(L1)](ttcH2)(ClO4)·EtOH·H2O (1), [Mn3(phen)6(ttc)](ClO4)3 (2), and Ni2(L2)(ttcH)(ClO4)2·6H2O·EtOH 
(3), where L1 = 2-[(E)-2-pyridylmethyleneamino]-N,N-bis[2-[(E)-2-pyridylmethyleneamino]ethyl]ethanamine, 
ttcH3 = trithiocyanuric acid, phen = 1,10-phenanthroline and L2 = 3-[2-(1,3,5,9,12-pentazacyclopentadec- 
3-yl)ethyl]-1,3,5,9,12-pentazacyclopentadecane. The structures of the ligands are depicted in Figure 1. 
Figure 1. Structural formulas of the ligands used. L1 = 2-[(E)-2-pyridylmethyleneamino]-
N,N-bis[2-[(E)-2-pyridylmethyleneamino]ethyl]ethanamine, phen = 1,10-phenanthroline, 
L2 = 3-[2-(1,3,5,9,12-pentazacyclopentadec-3-yl)ethyl]-1,3,5,9,12-pentazacyclopentadecane. 
 
We also attempted to prepare single crystals for X-ray analysis to confirm the stereochemistry of 
the compounds and characterize them by physico-chemical methods. Due to the presence of a positive 
charge in the molecule, prepared compounds can interact with the enzyme acetylcholinesterase (AChE; 
EC 3.1.1.7). Acetylcholine, the natural AChE substrate, contains a positively charged quaternary 
nitrogen, which is responsible for its interaction with the enzyme active site [32]. Therefore, the other 
goal of our study was to test the possible anticholinesterase activity of the synthesized complexes. 
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2. Results and Discussion 
2.1. Synthesis and Spectral Study 
[Fe(L1)](ttcH2)(ClO4)·EtOH·H2O (1) was prepared by the reaction of iron perchlorate, Schiff base 
(formed in situ), and ttcNa3 in an ethanol–water mixture. Although we expected the formation of a 
binuclear or polynuclear complex with a trithiocyanurate bridge, only a mononuclear Fe(II) complex 
was formed. Its composition was proposed on the base of elemental analysis and unambiguously 
confirmed by single crystal X-ray analysis. The deformed octahedral coordination of the central Fe(II) 
was also confirmed by Mössbauer spectroscopy (see Figure 2). The room temperature Mössbauer 
spectrum of 1 is composed of two doublets with the isomer shift values (0.28 and 0.14 mm s−1) typical 
of octahedral low-spin iron(II) complexes [33,34]. The doublet I with relative spectrum area  
A = 91.4% has a higher value of the quadrupole splitting parameter (q.s. = 0.28 mm s−1) than the 
doublet II (A = 8.6%, q.s. = 0.20 mm s−1). The two different values of quadrupole splitting show that 
there are two octahedrally coordinated iron centers with lower and higher distortion from the ideal 
octahedral arrangement, found in the polycrystalline material, but one arrangement is dominant. 
Similar spectra with two doublets were also found as a result of the octahedral arrangement distortion 
of the central atoms in Fe(II) complexes [12,13]. Our attempts to prepare Schiff base L1 in solid form 
were unsuccessful, but finally its sodium complex Na(L1)ClO4 (4) was obtained from the reaction 
mixture as light-yellow crystals, suitable for X-ray study. Complex 4 was also obtained by the reaction 
of L1 with sodium perchlorate. Its structure is discussed hereinafter.  
Figure 2. The room temperature Mössbauer spectrum of 1. The solid line results from least 
squares fitting of the data to the theoretical equation. 
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The complex [Mn3(phen)6(ttc)](ClO4)3 (2) was prepared according to Cermakova [35]. The complex 
was characterized by FTIR and Raman spectroscopies, MALDI-TOF mass spectrometry, magnetic and 
conductivity measurements. On the basis of different techniques, the trinuclear structure of complex 
was proposed, where three central manganese atoms are connected by trithiocyanurate(3-) bridge. 
Complex Ni2(L2)(ttcH)(ClO4)2·6H2O·EtOH (3) was prepared from Ni(bapen)(ClO4)2 (bapen = N,N'-
bis(3-aminopropyl)ethylenediamine) and in situ formation of macrocyclic ligand L2 by the 
condensation reaction of the terminal amino groups of bapen and ethylenediamine with formaldehyde. 
A similar preparation of macrocyclic complexes was for example published by Comba et al. [36]. 
Addition of ttcNa3 led to a formation of violet crystalline product. As our attempts to prepare crystals 
for X-ray analysis were unsuccessful we used mass spectroscopy to confirm the composition of 3. 
The ESI− mass spectra displays intense peaks at m/z = 947 and m/z = 848, corresponding  
to the binuclear molecular ion with ClO4− adducts of composition [Ni2(L2)(ttcH)(ClO4)2H−]− and 
[Ni2(L2)(ttcH)(ClO4)H−]−, respectively. The formation of perchlorate ion adducts is well known for 
such kinds of complex ions [31,37]. The peaks observed at lower m/z = 514, 455, 233 and 99, 
correspond to different fragments of the complex and its organic parts. 
The value of effective magnetic moment calculated per nickel(II) (μeff = 3.31 BM) for 3 is higher 
than that expected for the spin only value of octahedral or pentacoordinated nickel central atoms  
(μso = 2.83 BM). The higher value of the magnetic moment can be explained by a spin-orbital 
contribution to the spin only value. We can assume that the central nickel atoms are coordinated by 
four N atoms of macrocyclic ligand and by N or N, S set of donor atoms of ttcH− anion. 
2.2. X-ray Structures of [Fe(L1)](ttcH2)(ClO4)·EtOH·H2O (1) and Na(L1)ClO4 (4) 
The molecular structure of [Fe(L1)](ttcH2)(ClO4)·EtOH·H2O (1) is depicted in Figure 3, while 
selected bond lengths and angles are listed in Table 1. The crystal structure is stabilized by hydrogen 
bonds (see Table 2, Figure 4). The molecular structure of 1 consists of an electroneutral iron(II) 
complex, ttcH2− and ClO4− anions [disordered at two orientations with occupancies 0.536(8)/0.464(8)] 
and crystal water and EtOH molecules (mathematically squeezed of due to a disorder which could not 
be properly modeled). The central iron atom is coordinated by six N atoms of Schiff base L1 in a 
deformed octahedral arrangement. The bond lengths of the azomethine nitrogens N3A, N3B and N3C 
to central atom are in the range of 1.9527(16)-1.9635(16) Å, whereas the bond lengths of the pyridine 
nitrogens N6A, N6B and N6C are significantly longer (1.9720(16)-1.9997(15) Å). The N1 atom is out 
the coordination sphere of Fe atom with distance 3.4576(18) Å. 
The molecular structure of Na(L1)ClO4 (4) is depicted in Figure 5, while selected bond lengths and 
angles are listed in Table 3. Again, the perchlorate was disordered with occupancies 0.48(2)/0.52(2). 
The bond lengths to azomethine nitrogens are again shorter [2.580(14)-2.5406(13) Å] than those to 
pyridine nitrogens [2.6224(13)-2.7353(14) Å]. Moreover, atom N1 is in the coordination sphere of 
sodium, so Na is coordinated by seven N atoms. 
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Figure 3. Numbering scheme of 1 with atomic displacement ellipsoids drawn at  
30% probability level. Hydrogen atoms are omitted for clarity. Note the disordered 
perchlorate anion. 
 
Table 1. Selected bond lengths [Å] and angles [°] for 1. 
Fe-N3B  1.9527(16) N3B-Fe-N3C 96.12(7) N3C-Fe-N6A 174.37(7) 
Fe-N3A  1.9569(16) N3A-Fe-N3C 96.15(7) N6C-Fe-N6A 94.01(7) 
Fe-N3C  1.9635(16) N3B-Fe-N6C 171.87(7) N3B-Fe-N6B 80.89(6) 
Fe-N6C  1.9720(16) N3A-Fe-N6C 91.45(7) N3A-Fe-N6B 175.87(7) 
Fe-N6A  1.9764(16) N3C-Fe-N6C 81.10(7) N3C-Fe-N6B 87.31(6) 
Fe-N6B  1.9997(15) N3B-Fe-N6A 89.10(7) N6C-Fe-N6B 91.32(6) 
N3B-Fe-N3A 96.45(7) N3A-Fe-N6A 81.11(7) N6A-Fe-N6B 95.64(6) 
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Table 2. Hydrogen bonds for 1 [Å, °]. 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
O5-H52...O2B 0.931(18) 1.96(2) 2.825(7) 153 
O5-H52...O4A 0.931(18) 2.35(2) 3.243(10) 160 
O5-H52...O1B 0.931(18) 2.54(3) 3.334(9) 144 
O5-H52...Cl 0.931(18) 2.84(2) 3.765(2) 171 
N2-H2...S5i 0.88 2.52 3.3879(17) 169 
N4-H4...S1ii 0.88 2.40 3.2418(17) 160 
Symmetry transformations used to generate equivalent atoms: (i): −x+1,y +1/2,−z−1/2; (ii): −x+1,y−1/2,−z−1/2. 
Figure 4. Projection of the contents of the unit cell along b-axis (on left). Note the chains 
of ttc along the b-axis (on right). 
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Figure 5. Numbering scheme of 4 with atomic displacement ellipsoids drawn at  
30% probability level. Hydrogen atoms are omitted for clarity. Note the disordered 
perchlorate anion. 
 
Table 3. Selected bond lengths [Å] and angles [°] for 4. 
Na-N3A  2.5280(14) N3A-Na-N6C 115.01(5) N6C-Na-N6A 88.66(4) 
Na-N3C  2.5338(13) N3C-Na-N6C 64.88(4) N6B-Na-N6A 90.08(4) 
Na-N3B  2.5406(13) N3B-Na-N6C 141.07(5) N3A-Na-N1 65.01(4) 
Na-N6C  2.6224(13) N3A-Na-N6B 145.06(5) N3C-Na-N1 64.31(4) 
Na-N6B  2.6300(14) N3C-Na-N6B 110.99(5) N3B-Na-N1 65.04(4) 
Na-N6A  2.7353(14) N3B-Na-N6B 65.02(4) N6C-Na-N1 127.09(4) 
Na-N1  2.8431(12) N6C-Na-N6B 84.78(4) N6B-Na-N1 126.93(4) 
N3A-Na-N3C 103.63(4) N3A-Na-N6A 63.49(4) N6A-Na-N1 126.25(4) 
N3A-Na-N3B 103.60(4) N3C-Na-N6A 143.27(5) N6C-Na-N6A 88.66(4) 
N3C-Na-N3B 102.28(4) N3B-Na-N6A 114.01(4)   
The absolute configuration with Flack parameter −0.03(4) was determined. The crystal structure is 
stabilized by weak hydrogen bonds (see Table 4, Figure 6). Dihedral angles between the pyridine rings 
A, B and C are 89.70(10), 75.41(9) and 82.48(10) degrees for 1 and 53.78(8), 67.49(8) and 68.95(9) 
degrees for 4, respectively. 
  
Molecules 2014, 19 4346 
 
Table 4. Hydrogen bonds for 4 [Å, °]. 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
C2B-H2B1...O3Bi 0.99 2.56 3.483(11) 154 
C7A-H7A...O1B 0.95 2.59 3.264(10) 128 
Symmetry transformations used to generate equivalent atoms: (i): x−1/2,y−1/2,z. 
Figure 6. Projection of the contents of the unit cell along b-axis for 4. 
 
2.3. Anticholinesterase Activity 
The anticholinesterase activity of the complexes 1–3 and Fe(II), Mn(II) and Ni(II) salts were 
studied. The results of the study are presented in Table 5 and in Figure 7. As it is clearly seen, the 
newly prepared complexes of Fe(II) and Mn(II) were more than one hundred times and Ni(II) complex 
one thousand times stronger inhibitors if compared with corresponding standards (FeSO4, MnSO4, NiSO4). 
All the complexes show low solubility in water and are well soluble in DMF and DMSO. From the 
composition of [Fe(L1)](ttcH2)(ClO4)·EtOH·H2O (1) proved by X-ray it is obvious that in solution, 
complex cation and ttcH2 and ClO4 anions are formed. The complex cation is very stable due to the 
chelating Shiff base on the iron(II) center as was demonstrated, for example, in a study of oxygen 
bridged [(salen)FeOFe(salen)] (H2salen = N,N'- bis(salicylidene)ethylene diamine) complex [38]. Also 
in complexes [Fe(bpy)3](ttcH)·2bpy·7H2O and [Fe(phen)3](ttcH2)(ClO4)·2CH3OH·2H2O, where  
bpy = 2,2'-bipyridine, phen = 1,10-phenanthroline, the strong N-N ligands prevent the coordination of 
ttc anion to the metal center [13]. In the case of 1, we can assume that biological activity is caused by a 
combined effect of the individual components presented within the corresponding mixture in the 
medium used. 
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Table 5. Anticholinesterase activity of prepared complexes and standards in vitro. 
Compound IC50 [M] 95% CI [M] HillSlope 
[Fe(L1)](ttcH2)(ClO4)·EtOH·H2O (1) 4.35 × 10−5 1.34 × 10−5–1.41 × 10−4 0.0285 
[Mn3(phen)6(ttc)](ClO4)3 (2) 3.34 × 10−5 2.28 × 10−5–4.88 × 10−5 0.2280 
Ni2(L2)(ttcH)(ClO4)2·6H2O·EtOH (3) 1.20 × 10−5 9.46 × 10−6–1.51 × 10−5 0.0552 
FeSO4 >10−3 - - 
MnSO4 >10−3 - - 
NiSO4 1.29 × 10−2  −0.3920 
Figure 7. Anticholinesterase activity of complexes [Fe(L1)](ttcH2)(ClO4)·EtOH·H2O (1), 
[Mn3(phen)6(ttc)](ClO4)3 (2) and Ni2(L2)(ttcH)(ClO4)2·6H2O·EtOH (3). 
 
We can assume the stability of [Mn3(phen)6(ttc)](ClO4)3 (2) from the MALDI-TOF mass spectra, 
where the molecular peak was found [35]. Fragments of the complex were present in the spectra but 
we can expect that once the ttc bridge is formed it is bonded to the metal centre. We proved this by our 
attempt to prepare single crystals of 2. We dissolved the complex in DMSO and added diethyl ether to 
induce crystallization. After two weeks, we have only obtained from the solution single crystals of the 
dinuclear complex [Mn2(phen)4(ttc)](ClO4) (its structure will be published elsewhere), so it can be 
suggested that the complex undergoes dissociation but it can be considered as stable enough for 
biological activity testing. The complex Ni2(L2)(ttcH)(ClO4)2·6H2O·EtOH (3) was studied by ESI− 
mass spectroscopy and a molecular peak was found. Macrocyclic ligands form very stable complexes 
as it can be demonstrated on multinuclear zinc cyclen (1,4,7,10-tetraazacyclododecane) complexes 
with ttc bridges, which are stable in water at neutral pH [39]. In this case of 3, the biological activity is 
caused either by a combined effect of macrocyclic complex and ttc anion or by complex with 
coordinated ttc ligand. 
Due to the data obtained, further investigation of the anticholinesterase activity of the prepared 
complexes should be done. Because of the potency of tested compounds to inhibit cholinesterases, it 
could be considered to design structurally related complexes as potential drugs for Alzheimer´s disease 
or as prophylactics in case of nerve agent or pesticide poisoning. 
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3. Experimental Section  
3.1. Materials and Methods 
Safety note: Caution! Perchlorate salts of metal complexes with organic ligands are potentially 
explosive and should be handled with great care. The chemicals and solvents were supplied by Aldrich 
(St. Louis, MO, USA) and used without further purification. The C, H, N, and S analyses were carried 
out on an EA 1108 instrument (Fisons Instruments, Rodano, Italy). The magnetochemical data were 
obtained by Faraday method at 293 K using a M-25D electrobalance (Sartorius, Elk Grove, IL, USA). 
Hg[Co(SCN)4] was used as a calibrant. The correction for diamagnetism was calculated using Pascal’s 
constants. The transmission Mössbauer spectrum was recorded using a Mössbauer spectrometer in 
constant acceleration mode with a 57Co(Rh) source. Isomer shift parameters are related to metallic iron 
(the calibration temperature of 300 K). 
The ESI- mass spectra were recorded on a ZMD 2000 mass spectrometer (Waters, Milford, MA, 
USA). The mass-monitoring interval was m/z 10–1500. The spectra were collected using 3.0 s cyclical 
scans and applying the sample cone voltages 20, 30 or 40 V, at the source block temperature 80 °C, 
desolvation temperature 150 °C and desolvation gas flow rate 200 l/h. The mass spectrometer was directly 
coupled to a MassLynx data system. All m/z interpretations were based on 35Cl and 58Ni, respectively. 
The crystallographic data for the structures 1 and 4 has been deposited with the Cambridge 
Crystallographic Data Centre as supplementary publication no. 960842 and 960843. Copies of the data 
can be obtained, free of charge, on application to CCDC, 12 Union Road, Cambridge, CB2 1EZ, UK 
(fax: +44-(0)1223-336033 or e-mail: deposit@ccdc.cam.ac.uk). 
3.2. Preparation of the Complexes  
3.2.1. [Fe(L1)](ttcH2)(ClO4)·EtOH·H2O (1) 
Schiff base L1 was prepared in situ by condensation of tris(2-aminoethyl)amine (150 µL, 1 mmol) 
and 2-pyridinecarboxaldehyde (285 µL, 3 mmol) in EtOH (30 mL). The mixture was heated to boiling 
and after cooling, added to stirred EtOH solution (30 mL) of Fe(ClO4)2·6H2O (0.36 g, 1 mmol). The 
violet mixture was heated at 60 °C for 30 min. A little amount of precipitate disappeared after addition 
of water (20 mL). After cooling, ttcNa3·9H2O (0.4 g, 1 mmol) in water (5 mL) was added dropwise to 
the solution. A small amount of precipitate was filtered off. A dark violet solution was left for the 
crystallization. After a week, violet crystals suitable for X-ray analysis were collected. Yield: 62%. 
Anal. Calcd.: C, 43.1; H, 4.6; N, 17.3; S, 11.9. Found: C, 42.8; H, 4.5; N, 17.1; S, 11.3%. Mössbauer 
spectrum (300 K): doublet I with isomer shift (i.s.) = 0.28 ± 0.01 mm s−1, quadrupole splitting  
(q.s.) = 0.18 ± 0.00 mm s−1, half-width of the spectral line () = 0.26 ± 0.01 mm s−1 and relative 
spectrum area (A) = 91.4%; doublet II with i.s. = 0.14 ± 0.01 mm s−1, q.s. = 0.20 ± 0.01 mm s−1,  
 = 0.23 ± 0.01 mm s−1, A = 8.6%. 
3.2.2. [Mn3(phen)6(ttc)](ClO4)3 (2) 
The complex was prepared according to [35]. 1,10-Phenanthroline (phen) (0.4 g, 2 mmol) in EtOH 
(15 mL) was added to an EtOH solution (15 mL) of manganese(II) perchlorate hexahydrate (0.36 g,  
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1 mmol). The yellow precipitate was dissolved by addition of water (40 mL). Then, ttcNa3·9H2O (0.14 g, 
0.35 mmol) in water (1 mL) was added in drops to the solution. The yellow precipitate was filtered off, 
washed several times with water and EtOH and dried at 60 °C. Yield: 78%. Anal. Calcd.: C, 52.4; H, 
2.8; N, 12.2; S, 5.6. Found: C, 51.8; H, 2.9; N, 12.1; S, 5.2%. 
3.2.3. Ni2(L2)(ttcH)(ClO4)2·6H2O·EtOH (3) 
N,N'-bis(3-aminopropyl)ethylenediamine (bapen) (0.55 mL, 3 mmol) was added to an EtOH 
solution (100 mL) of Ni(ClO4)2·6H2O nickel(II) perchlorate hexahydrate (1.11 g, 3 mmol) and stirred 
for 1 h. Triethylamine (0.84 mL, 6 mmol), ethylenediamine (0.1 mL, 1.5 mmol) and paraformaldehyde 
(0.18 g, 6 mmol) were added and the mixture was stirred and refluxed for 24 h. The mixture was 
filtered while hot and the solution was left to cool to room temperature. A solution of ttcNa3·9H2O (0.2 g, 
0.5 mmol) in water (5 mL) was added in form of drops. The colour of the solution turned to dark violet 
and microcrystals of the product were collected after 3 h on a frit, washed several times with EtOH and 
dried in air. Yield: 47%. Anal. Calcd.: C, 29.4; H, 6.5; N, 16.5; S, 8.7. Found: C, 28.8; H, 6.1; N, 16.2; 
S, 8.1%. MS (ESI−): m/z = 947 [Ni2(L2)(ttcH)(ClO4)2H−]−, 848 [Ni2(L2)(ttcH)(ClO4)H−]−, 514 [Ni(L2)H−]−, 
455 [(L2)H−]−, 233 [Ni(ttcH)H−]−, 99 ClO4−. μeff = 3.31 BM. 
3.2.4. Na(L1)ClO4 (4) 
Schiff base L1 was prepared by condensation of tris(2-aminoethyl)amine (150 µL, 1 mmol) and  
2-pyridinecarboxaldehyde (285 µL, 3 mmol) in EtOH (30 mL). The mixture was heated to boiling and 
after cooling EtOH solution (2 mL) of NaClO4·H2O (0.14 g, 1 mmol) was added. Obtained precipitate 
was collected on frit, washed with EtOH and dried at 40 °C. Yield: 53%. Anal. Calcd.: C, 53.8; H, 5.1; 
N, 18.3. Found: C, 53.2; H, 4.9; N, 18.1%. 
3.3. X-ray Crystallography 
X-ray data of 1 and Na(L1)ClO4 (4) were collected on a SMART CCD diffractometer (Siemens, 
Madison, WI, USA) with Mo-Kα radiation (λ = 0.71073 Å, graphite monochromator). The crystal was 
cooled to 173(2) K by a flow of nitrogen gas using the LT-2A device. A full sphere of reciprocal space 
was scanned by 0.3 steps in ω with a crystal-to-detector distance of 3.97 cm. Preliminary orientation 
matrices were obtained from the first frames using SMART [40]. The collected frames were integrated 
using the preliminary orientation matrix which was updated every 100 frames. Final cell parameters 
were obtained by refinement of the positions of reflections with I > 10σ (I) after integration of all the 
frames using SAINT software [40]. The data were empirically corrected for absorption and other 
effects using the SADABS program [41]. The structures were solved by direct methods and refined by 
full-matrix least squares on all |F2| data using SHELXTL software [42].  
X-ray data of 1: The largest peak and hole on the final difference map were 0.846 and −0.467 e.Å−3. 
Important crystallographic parameters are as follows: C29H37ClN10O6S3Fe, wavelength 0.71073 Å, 
monoclinic, space group P21/c, a = 12.5826(7), b = 12.4592(7), c = 22.2479(13) Å, β = 96.098(1)°, 
volume 3468.0(3) Å3, Z = 4, density (calc.) 1.550 Mg/m3, absorption coefficient 0.751 mm−1,  
F(000) = 1680, crystal size 0.42 × 0.42 × 0.10 mm, index ranges −17 ≤ h ≤ 17, −17 ≤ k ≤ 17, −30 ≤ l ≤ 30, 
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reflections collected/independent 51041/9351 (Rint = 0.0369), refinement method full-matrix  
least-squares on F2, data/restraints/parameters 9351/71/499, goodness-of fit on F2 = 1.016, final  
R1 (I > 2σ(I) data) = 0.0384, wR2 = 0.1064, final R1 (all data) = 0.0501, wR2 = 0.1120. 
X-ray data of 4: The largest peak and hole on the final difference map were 0.367 and −0.205 e.Å−3. 
Important crystallographic parameters are as follows: C24H27N7NaClO4, wavelength 0.71073 Å, 
monoclinic, space group Cc, a = 21.8301(8), b = 8.5329(3), c = 15.1592(5) Å, β = 112.719(1)°, volume 
2604.67(16) Å3, Z = 4, density (calc.) 1.367 Mg/m3, absorption coefficient 0.208 mm−1, F(000) = 1120, 
crystal size 0.32 x 0.22 x 0.12 mm, index ranges −33 ≤ h ≤ 33, −13 ≤ k ≤ 13, −22 ≤ l ≤ 22, reflections 
collected/independent 22608/9247 (Rint = 0.0238), refinement method full-matrix least-squares on F2, 
data/restraints/parameters 9247/70/399, goodness-of fit on F2 = 1.027, final R1 (I > 2σ(I) data) = 0.0396, 
wR2 = 0.0967, final R1 (all data) = 0.0513, wR2 = 0.1025. 
3.4. Biological Activity Testing 
In vitro inhibition test was conducted as described earlier [43]. Solutions of the prepared 
Fe(L1)](ttcH2)(ClO4)·EtOH·H2O (1), [Mn3(phen)6(ttc)](ClO4)3 (2), and Ni2(L2)(ttcH)(ClO4)2·6H2O·EtOH 
(3) complexes of appropriate concentrations (concentration range from 10−7 to 10−1 M; 500 µL) were 
added to the suspension of rat brain homogenate (10 w/v in distilled water; 500 µL), solution of sodium 
chloride (3 M; 2.5 mL) and water (20 mL). Subsequently, a solution of acetylcholine iodide (0.02 M; 
2.0 mL) was added (=starting of the enzyme reaction). The enzyme activity was immediately 
determined using of automatic titrator RTS 822 (Radiometer, Bronshoj, Denmark). The IC50 values 
were calculated from a plot of percent inhibition of cholinesterases versus its concentration. To show 
that not only Fe(II), Mn(II) or Ni(II) cation in complex causes the anticholinesterase activity, FeSO4, 
MnSO4 and NiSO4 were used as standards for comparison. Nonlinear regression was performed using 
software for statistical analysis GraphPad Prism version 4 for Windows (GraphPad Software, San 
Diego, CA, USA; www.graphpad.com). 
4. Conclusions  
Metal based complexes play important roles in numerous applications, including drugs. Their 
effects on enzyme pathways can be reversible and/or irreversible, which is of great interest for 
physicians, because such compounds can help alter disease-connected pathways. In this study, we 
prepared and characterized complexes of Fe(II), Mn(II) and Ni(II) with a combination of Schiff base, 
nitrogen-donor ligand or macrocyclic ligand and trithiocyanuric acid (ttcH3). Besides their structural 
characterization, their effect on anticholinesterase activity was also examined. 
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